Wockhardt Ltd
Pharmaceuticals & Biotechnology | Small Cap
Wockhardt Ltd, a company in the Healthcare Services industry, showcases a mixed financial performance. The company demonstrates strong solvency, driven by healthy debt and equity management. Growth prospects are promising, particularly in revenue and operating profit. However, certain areas raise concern. The company's liquidity position appears weak, suggesting potential challenges in meeting short-term obligations. Efficiency in utilizing assets is also a concern. Profitability metrics are inconsistent, with strong gross and operating margins offset by low returns on equity and assets. Overall, Wockhardt shows potential for growth and stability, but needs to address its liquidity and efficiency challenges to achieve sustained financial health.
Latest Report
View AllLatest News
View AllThe Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.
- Valuation MetricsNeutral
- Market Metrics
- Stock Reports
- Stock News
- Growth Ratio6.00
- Financial Ratio4.40
- Profitability Ratio6.60
- Efficiency Ratio4.67
- Coverage Ratio2.00
- Solvency Ratio10.00
- Liquidity Ratio2.00
- Peer Assessment
- Management AssessmentBalanced
- Risk AssessmentWeak
- 1 HourNeutral
- 2 HoursNeutral
- 4 HoursBullish
- 1 DayBullish
- 1 WeekBullish
- 1 MonthBullish
Wockhardt Ltd, a company in the Healthcare Services industry, showcases a mixed financial performance. The company demonstrates strong solvency, driven by healthy debt and equity management. Growth prospects are promising, particularly in revenue and operating profit. However, certain areas raise concern. The company's liquidity position appears weak, suggesting potential challenges in meeting short-term obligations. Efficiency in utilizing assets is also a concern. Profitability metrics are inconsistent, with strong gross and operating margins offset by low returns on equity and assets. Overall, Wockhardt shows potential for growth and stability, but needs to address its liquidity and efficiency challenges to achieve sustained financial health.
Latest Report
View AllLatest News
View AllThe Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.
Overall Valuation Score
P/E RATIO (TTM)
103.08
Industry Median
28.62
Small Cap Median
27.17
P/E RATIO
153.40
P/B RATIO
6.62
Industry Median
3.17
Small Cap Median
2.62
P/S RATIO
8.49
Industry Median
3.42
Small Cap Median
2.55
Others
PEG RATIO
0.00
EV/EBITDA RATIO
44.27
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹2011.1 as on Jun 20, 2026.
Unlock Live Chart
Please login to view interactive real-time technical charts powered by TradingView.
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
0.00
Today's Low
0.00
Today's High
Concall Report⬤11th Jun 26
Q4 FY26 Earnings Conference Call
BULLISH SENTIMENT
The company demonstrates strong growth in revenue and operating profit. The company has experienced decline in earnings per share, and net income growth rate is also low. However, the company has been able to grow its assets. The company's growth prospects appear to be promising, particularly in revenue and operating profit. Overall, the company's growth ratio indicates a mixed performance.
| Growth Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue Growth Rate | 19.28 | -17.93 | 5.55 | 7.65 | 11.99 |
| Operating Profit Growth Rate | -573.02 | -66.11 | -9.9 | 331.87 | 65.9 |
| Earnings Per Share (EPS) Growth | -135.56 | 129.04 | -22.22 | -90.42 | -553.63 |
| Asset Growth Rate | 6.08 | -6.87 | -0.48 | 6.38 | 6.36 |
| Net Income Growth Rate | -140.49 | 122.58 | -23.99 | -87.92 | -449.12 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
The company's financial ratios present a mixed picture. Adjusted earnings per share and dividend per share are not available. Cash earnings per share is at a low level. Book value per share is at an average level. Capital expenditures are well managed. Overall, the company's financial performance appears to be mixed.
| Financial Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Adjusted Earnings Per Share (Adjusted EPS) | -10.14 | -27.43 | -27.47 | -4.14 | 15.8 |
| Cash Earnings Per Share (Cash EPS) | -2.22 | -25.69 | -16.17 | 9.88 | 26.3 |
| Book Value Per Share | 267.29 | 232.92 | 218.12 | 268.7 | 304.94 |
| Dividend Per Share (DPS) | 0 | 0 | 0 | 0 | 0 |
| Capital Expenditures (CapEx) | 211 | 130 | 150 | 355 | 314 |
Adjusted Earnings Per Share (Adjusted EPS)
Cash Earnings Per Share (Cash EPS)
Book Value Per Share
Dividend Per Share (DPS)
Capital Expenditures (CapEx)
The company's profitability ratios are mixed. Gross profit margin and operating margin are strong, indicating that the company is generating a healthy profit from its sales. Return on equity and net margin are low. Return on assets is also low. Overall, the company's profitability ratio indicates a mixed performance.
| Profitability Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Gross Profit Margin | 1.58 | -5.66 | -4.72 | 5.84 | 12.6 |
| Return on Capital Employed (ROCE) | 1 | 0 | -1 | 4 | 8 |
| Return on Equity (ROE) | -7.25 | -18.52 | -14.05 | -1.31 | 4.03 |
| Return on Assets (ROA) | 3.63 | 1.32 | 1.2 | 4.85 | 7.57 |
| Operating Margin | 9.23 | 3.81 | 3.25 | 13.05 | 19.33 |
| Net Margin | -8.64 | -23.43 | -16.87 | -1.89 | 5.9 |
Gross Profit Margin
Return on Capital Employed (ROCE)
Return on Equity (ROE)
Return on Assets (ROA)
Operating Margin
Net Margin
The company's efficiency in utilizing its assets is mixed. Fixed asset, inventory, and receivables turnover ratios are all very low, indicating that the company is not efficiently utilizing these assets to generate revenue. However, the days sales in inventory and receivable days are at an appropriate levels, indicating that the company is managing its inventory and receivables well. The capital turnover ratio is also low, suggesting that the company is not generating enough revenue from its capital investments.
| Efficiency Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Fixed Asset Turnover Ratio | 0.93 | 0.87 | 0.97 | 1.1 | 0.75 |
| Inventory Turnover Ratio | 4.05 | 3.93 | 4.51 | 4.16 | 3.66 |
| Receivables Turnover Ratio | 3.52 | 3.09 | 3.95 | 4.71 | 5.4 |
| Days Sales in Inventory Ratio | 90.12 | 92.88 | 80.93 | 87.74 | 99.73 |
| Receivable Days | 103.69 | 118.12 | 92.41 | 77.49 | 67.59 |
| Capital Turnover Ratio | 0.71 | 0.68 | 0.62 | 0.53 | 0.51 |
Fixed Asset Turnover Ratio
Inventory Turnover Ratio
Receivables Turnover Ratio
Days Sales in Inventory Ratio
Receivable Days
Capital Turnover Ratio
The company's coverage ratios are low. The interest coverage ratio is minimal, indicating that the company may have difficulty meeting its interest obligations. The equity dividend coverage ratio is also low, suggesting that the company may not be able to sustain its dividend payments. Overall, the company's coverage ratios indicate potential financial strain in meeting its obligations to lenders and shareholders.
| Coverage Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Interest Coverage Ratio | -0.37 | -1.07 | -0.38 | 0.94 | 2.12 |
| Equity Dividend Coverage Ratio |
Interest Coverage Ratio
Equity Dividend Coverage Ratio
The company shows strong solvency. It has a healthy debt ratio and debt-to-equity ratio, indicating a balanced capital structure. The equity ratio is also strong. The company's debt-to-asset ratio is at a manageable level, suggesting a reasonable proportion of assets are financed by debt. Overall, the company appears to be in a stable financial position with regard to its long-term obligations.
| Solvency Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Debt Ratio | 0.15 | 0.13 | 0.25 | 0.24 | 0.25 |
| Debt to Equity Ratio | 0.18 | 0.15 | 0.33 | 0.32 | 0.33 |
| Equity Ratio | 0.85 | 0.87 | 0.75 | 0.76 | 0.75 |
| Debt To Asset Ratio | 0.08 | 0.07 | 0.15 | 0.17 | 0.19 |
Debt Ratio
Debt to Equity Ratio
Equity Ratio
Debt To Asset Ratio
The company's liquidity position is weak. The current, quick, and cash ratios are all at minimal levels, indicating that the company might face difficulties in meeting its short-term liabilities with its current assets. This could be a point of concern for investors and creditors. Low operating cash flow ratio indicates the company's operational activities are not generating sufficient cash to cover its short-term obligations. A positive aspect is that the company can improve working capital management to enhance financial flexibility.
| Liquidity Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Current Ratio | 0.93 | 0.81 | 0.97 | 1.23 | 1.48 |
| Quick Ratio | 0.72 | 0.64 | 0.76 | 0.92 | 1.05 |
| Cash Ratio | 0.11 | 0.03 | 0.17 | 0.08 | 0.12 |
| Operating Cash Flow Ratio | 0.11 | 0.04 | 0.07 | -0.01 | 0.19 |
Current Ratio
Quick Ratio
Cash Ratio
Operating Cash Flow Ratio
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | J B Chemicals & Pharmaceuticals Ltd | 8.14 | 49.64 | Overvalued | 1107.00 | 41.98 | 709.00 |
| 2 | Gland Pharma Ltd | 7.91 | 35.27 | Overvalued | 1630.00 | 78.88 | 1027.00 |
| 3 | Neuland Laboratories Ltd | 7.84 | 61.14 | Highly Overvalued | 574.00 | 283.01 | 364.00 |
| 4 | Granules India Ltd | 7.73 | 32.77 | Highly Overvalued | 1185.00 | 16.17 | 595.00 |
| 5 | Ajanta Pharma Ltd | 7.72 | 36.27 | Neutral | 1395.00 | 75.78 | 1056.00 |
| 6 | Alembic Pharmaceuticals Ltd | 7.54 | 22.23 | Undervalued | 1118.00 | 32.58 | 671.00 |
| 7 | Syngene International Ltd | 7.44 | 56.08 | Overvalued | 918.00 | 7.55 | 317.00 |
| 8 | Emcure Pharmaceuticals Ltd | 7.40 | 36.42 | Neutral | 1865.00 | 38.66 | 941.00 |
| 9 | Marksans Pharma Ltd | 7.24 | 28.16 | Neutral | 601.00 | 6.64 | 420.00 |
| 10 | ERIS Lifesciences Ltd | 7.15 | 32.39 | Neutral | 1120.00 | 17.61 | 648.00 |
| 11 | Piramal Pharma Ltd | 5.83 | -64.86 | Neutral | 922.00 | 5.27 | -326.00 |
| 12 | Jubilant Pharmova Ltd | 5.71 | 38.62 | Neutral | 1260.00 | 1.25 | 398.00 |
| 13 | Natco Pharma Ltd | 5.69 | 11.22 | Neutral | 1436.00 | 71.55 | 1418.00 |
| 14 | Strides Pharma Science Ltd | 5.55 | 18.41 | Undervalued | 925.00 | 19.92 | 575.00 |
| 15 | Jeena Sikho Lifecare Ltd | 5.52 | 31.22 | Neutral | 349.00 | 17.87 | 222.00 |
| 16 | Wockhardt Ltd | 5.07 | 153.40 | Neutral | 652.00 | 19.51 | 199.00 |
| 17 | Pfizer Ltd | 3.45 | 45.16 | Neutral | -82.00 | 157.92 | 300.00 |
| 18 | Procter & Gamble Health Ltd | 3.45 | 31.71 | Neutral | 457.00 | 196.94 | 327.00 |
| 19 | Sanofi India Ltd | 3.45 | 18.59 | Neutral | 491.00 | 134.52 | 413.00 |
The management effectiveness of Wockhardt Ltd shows mixed results. While there are improvements in sales and operating profit margin (OPM) recently, the company's profitability is inconsistent, with net losses reported in several quarters and years. The declining promoter holding raises concerns about long-term commitment. The negative return on capital employed (ROCE) and return on equity (ROE) indicate inefficient use of capital and shareholder funds. Overall, management faces challenges in achieving sustained profitability. Therefore, the management effectiveness is rated as Orange.
| Category | Metric | Value | Assessment |
|---|---|---|---|
| PROS | Improving OPM | [18% in Dec 2024] | Operational efficiency is improving. |
| CONS | Declining Promoter Holding | [From 74.25% in Mar 2017 to 49.09% in Mar 2025] | Confidence and alignment with shareholders may be weakening. |
| CONS | Negative ROCE | [-1% in Mar 2024] | Capital utilization remains unproductive. |
| CONS | Negative ROE | [-1% in Return on Equity(Last Year)] | Shareholder funds are not yielding good returns. |
Financial Performance & Growth
Wockhardt Ltd demonstrates inconsistent financial performance. While quarterly sales show some growth, the annual sales growth has been volatile. The company has struggled to maintain consistent profitability, with frequent losses. This inconsistency raises concerns about the sustainability of the company's financial performance.
| Metric | 2014-2016 | 2017-2019 | 2020-2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Sales Growth (%) | -7.25% | -7.07% | 2.75% | -17.93% | 5.55% | 7.65% |
| OPM (%) | 16% | -0.33% | 4% | 4% | 3% | 13% |
| Net Profit + | 502.67 | -370 | 122 | -621 | -472 | -57 |
Capital Efficiency & Returns
Wockhardt's capital efficiency and returns are poor, as indicated by negative ROCE and ROE values. This suggests that the company is not effectively utilizing its capital or generating adequate returns for its shareholders. The negative returns raise concerns about the company's ability to create value.
| Metric | 2014-2016 | 2017-2019 | 2020-2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| ROCE (%) | 11.67% | -1% | 3.67% | -0% | -1% | 4% |
Financial Health & Prudence
Wockhardt's financial health presents mixed signals. The company has a substantial amount of debt, but it appears to be managing its interest obligations. However, the inconsistent profitability and negative net worth raise concerns about long-term financial stability.
| Metric | 2014-2016 | 2017-2019 | 2020-2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Borrowings | 2429 | 3761 | 2882 | 2184 | 2356 | 2021 |
| Interest | 89 | 248.33 | 282.33 | 302 | 305 | 254 |
| Dividend Payout | 22.33% | -18.67% | 0% | 0% | 0% | 0% |
Shareholding & Ownership Structure
The shareholding pattern of Wockhardt Ltd reveals a concerning trend of decreasing promoter holding. This decline in promoter ownership raises questions about the long-term commitment and confidence of the company's leadership. While institutional holdings have increased, they may not fully offset the negative signal from reduced promoter stake.
| Metric | Mar 2017 | Mar 2019 | Mar 2021 | Mar 2023 | Mar 2025 |
|---|---|---|---|---|---|
| Promoters + | 74.25% | 74.07% | 72.12% | 59.31% | 49.09% |
| FIIs + | 4.55% | 4.74% | 3.10% | 2.78% | 6.82% |
| DIIs + | 2.71% | 2.55% | 0.09% | 0.22% | 10.58% |
Wockhardt Ltd faces financial and operational risks. The company's negative profitability, high debt levels, and declining promoter holding contribute to an elevated risk profile. Inconsistent segment performance and moderate volatility in sales and profit growth exacerbate these risks. These factors indicate that Wockhardt is exposed to vulnerabilities that could affect its sustainability.
Contingent liability evaluation
There is no specific data available on contingent liabilities.
Segment performance volatility
There is no specific data available on segment performance volatility.
Foreign exchange or interest rate exposure
There is no specific data available on foreign exchange or interest rate exposure.
Regulatory compliance cost trends
There is no specific data available on regulatory compliance cost trends.
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 101997.93Bullish
- SMA 202019.39Bearish
- SMA 501959.61Bullish
- EMA 102006.37Bullish
- EMA 201999.97Bullish
- EMA 501972.33Bullish
- DEMA 102006.72Bullish
- DEMA 202019.36Bearish
- DEMA 502009.79Bullish
- TEMA 102001.26Bullish
- TEMA 202013.79Bearish
- TEMA 502013.01Bearish
- MACD12.40Bearish
- ADX21.28Weak Trend
- IndicatorValueSignal
- RSI55.66Neutral
- CCI-16.08Neutral
- ROC 91.67Bullish
- ROC 14-0.37Bearish
- ROC 255.17Bullish
- Stoch K33.27Neutral
- Stoch D29.53Neutral
- IndicatorValueSignal
- BB Upper2080.85Neutral
- BB Middle2019.39Neutral
- BB Lower1957.93Neutral
- ATR30.76Low Volatility
- IndicatorValueSignal
- MFI60.11Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 2 Hours Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 102018.87Bearish
- SMA 201974.72Bullish
- SMA 501953.88Bullish
- EMA 102003.97Bullish
- EMA 201985.44Bullish
- EMA 501942.03Bullish
- DEMA 102019.66Bearish
- DEMA 202016.65Bearish
- DEMA 502020.26Bearish
- TEMA 102013.23Bearish
- TEMA 202026.98Bearish
- TEMA 502002.31Bullish
- MACD23.83Bullish
- ADX32.25Strong Trend
- IndicatorValueSignal
- RSI58.00Neutral
- CCI52.71Neutral
- ROC 9-0.62Bearish
- ROC 145.35Bullish
- ROC 254.63Bullish
- Stoch K47.71Neutral
- Stoch D46.30Neutral
- IndicatorValueSignal
- BB Upper2086.80Neutral
- BB Middle1974.71Neutral
- BB Lower1862.63Neutral
- ATR42.54Low Volatility
- IndicatorValueSignal
- MFI73.26Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 4 Hours Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 101975.15Bullish
- SMA 201940.86Bullish
- SMA 501850.99Bullish
- EMA 101985.38Bullish
- EMA 201958.28Bullish
- EMA 501854.06Bullish
- DEMA 102013.71Bearish
- DEMA 202011.24Bullish
- DEMA 502036.79Bearish
- TEMA 102022.93Bearish
- TEMA 201998.78Bullish
- TEMA 50N/AN/A
- MACD39.20Bullish
- ADX34.69Strong Trend
- IndicatorValueSignal
- RSI59.10Neutral
- CCI98.30Neutral
- ROC 95.56Bullish
- ROC 149.34Bullish
- ROC 25-2.23Bearish
- Stoch K59.95Neutral
- Stoch D66.08Neutral
- IndicatorValueSignal
- BB Upper2052.98Neutral
- BB Middle1940.86Neutral
- BB Lower1828.74Neutral
- ATR70.18Low Volatility
- IndicatorValueSignal
- MFI75.40Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 33 Technical Indicators From The 1 Day Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 101932.52Bullish
- SMA 201911.38Bullish
- SMA 501653.85Bullish
- SMA 1001484.23Bullish
- SMA 2001442.48Bullish
- EMA 101952.24Bullish
- EMA 201886.67Bullish
- EMA 501710.58Bullish
- EMA 1001577.93Bullish
- EMA 2001489.04Bullish
- DEMA 102001.96Bullish
- DEMA 202021.46Bearish
- DEMA 501921.63Bullish
- DEMA 1001731.80Bullish
- DEMA 2001615.16Bullish
- TEMA 101991.73Bullish
- TEMA 202019.44Bearish
- TEMA 502035.40Bearish
- TEMA 1001866.72Bullish
- TEMA 2001629.67Bullish
- MACD96.08Bearish
- ADX37.82Strong Trend
- IndicatorValueSignal
- RSI62.08Neutral
- CCI49.36Neutral
- ROC 14-6.59Bearish
- ROC 2529.98Bullish
- Stoch K38.38Neutral
- Stoch D33.87Neutral
- IndicatorValueSignal
- BB Upper2200.13Neutral
- BB Middle1911.38Neutral
- BB Lower1622.63Neutral
- ATR110.11Low Volatility
- IndicatorValueSignal
- MFI61.18Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 21 Technical Indicators From The 1 Week Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bearish
- IndicatorValueSignal
- SMA 201459.83Bullish
- SMA 501453.72Bullish
- EMA 201549.24Bullish
- EMA 501442.37Bullish
- DEMA 201688.88Bullish
- DEMA 501576.74Bullish
- TEMA 201812.38Bullish
- TEMA 501551.85Bullish
- MACD124.94Bullish
- ADX27.75Strong Trend
- IndicatorValueSignal
- RSI66.13Neutral
- CCI220.20Overbought
- ROC 1449.12Bullish
- ROC 2537.34Bullish
- Stoch K73.22Neutral
- Stoch D75.21Neutral
- IndicatorValueSignal
- BB Upper1938.65Neutral
- BB Middle1459.83Neutral
- BB Lower981.01Neutral
- ATR188.11Low Volatility
- IndicatorValueSignal
- MFI81.59Overbought
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 25 Technical Indicators From The 1 Month Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 61465.50Bullish
- SMA 121469.54Bullish
- SMA 241335.87Bullish
- EMA 61540.82Bullish
- EMA 121446.31Bullish
- EMA 241272.34Bullish
- DEMA 61665.09Bullish
- DEMA 121594.81Bullish
- DEMA 241603.20Bullish
- TEMA 61761.32Bullish
- TEMA 121582.43Bullish
- TEMA 241653.63Bullish
- MACD327.97Bullish
- ADX41.02Strong Trend
- IndicatorValueSignal
- RSI66.12Neutral
- CCI134.78Overbought
- ROC 25258.62Bullish
- ROC 50670.64Bullish
- Stoch K70.24Neutral
- Stoch D80.31Overbought
- IndicatorValueSignal
- BB Upper1816.67Overbought
- BB Middle1421.14Neutral
- BB Lower1025.61Neutral
- ATR281.31High Volatility
- IndicatorValueSignal
- MFI75.37Neutral